Galera Therapeutics Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Galera Therapeutics Inc 's ROA in the first quarter of 2026?
Galera Therapeutics Inc achieved a return on average assets (ROA) of 1040.85 % in its first quarter of 2026 a new company high.

Despite the company's net income deteriorating, Galera Therapeutics Inc was able to improve its ROA compared to the fourth quarter of 2025.

However, within the Healthcare sector Galera Therapeutics Inc achieved the highest return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 7, from total ROA ranking in the fourth quarter of 2025 at 10.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	-19.54 %	-28.76 %	-43.8 %	-63.08 %	-60.48 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	64	64	-7	-11	-15
Return On Assets (TTM)	1040.85 %	980.8 %	-90.81 %	-140.55 %	-140.05 %
GRTX's Total Ranking	# 7	# 10	# 4353	# 4576	# 4653
Total Assets (TTM) in million	6	7	5	6	8
Seq. Total Assets Change	-14.34 %	43.86 %	-17.29 %	-21.05 %	-24.16 %
Seq. Net Income Change	-	-	-	-	-

GRTX's 5 Years Annual ROA >> Back to GRTX Management Effectiveness >> Compare GRTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 1
Sector	# 1
Overall	# 6

Return On Assets Statistics
High	Average	Low
1040.85 %	-16.38 %	-146.85 %
(Mar 31 2026)		(Sep 30 2023)

Financial Statements
Galera Therapeutics Inc 's Assets	$ 6 million	GRTX's Balance sheet
Galera Therapeutics Inc 's Income	$ -1 million	Quarterly GRTX's Income Statement
GRTX's Income by Division		See GRTX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-28.76 %	-61.36 %	-40.64 %	-47.14 %	-0.94 %
Total Assets in million	7	10	26	44	83
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	64	-19	-59	-62	-81
Annual Return On Assets	882.77 %	-185.46 %	-226.01 %	-141.3 %	-96.67 %

GRTX's 5 Years Annual ROA >> Back to GRTX Management Effectiveness >> Compare GRTX ROA to its Competitors

Comment on GRTX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 882.77 % compared to prior year, due to annual net income growth of % to $63.52 million, and due to decline of value in Galera Therapeutics Inc 's assets by -28.76 % to $7.20 million, compared to $7.20 a year before.

More Return On Assets Ratios
GRTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GRTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GRTX's Competitors
Subscribers only: Roa for Galera Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for GRTX's Customers

You may also want to know
GRTX's Roi	GRTX's Inventory Turnover Ratio	GRTX's Growth Rates	GRTX's Dividend Comparisons
	GRTX's Profitability Ratios	GRTX's Asset Turnover Ratio	GRTX's Dividend Growth
GRTX's Roe	GRTX's Valuation Ratios	GRTX's Financial Strength Ratios	GRTX's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector	ROA
Stablecoin Development Corporation	1,049.51 %
Galera Therapeutics Inc	1,040.85 %
Glucotrack Inc	220.10 %

Date modified: 2026-09-26T07:37:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.